Clinical Proteomics

, Volume 2, Issue 1–2, pp 1–4 | Cite as

Clinical proteomics

My view of the current issues
  • Daniel W. Chan
Open Access


  1. 1.
    Colantonio, D. A. and Chan, D. W. (2005) The clinical application of proteomics. Clin. Chim. Acta 35, 151–158.CrossRefGoogle Scholar
  2. 2.
    Anderson, N. L. and Anderson, N. G. (2002) The human plasma proteome: history, character, and diagnostic prospects. Mol. Cell Proteomics 1, 845–867.PubMedCrossRefGoogle Scholar
  3. 3.
    Drake, S. K., Bowen, R. A., Remaley, A. T., and Hortin, G. L. (2004) Potential interferences from blood collection tubes in mass spectrometric analyses of serum polypeptides. Clin. Chem. 50, 2398–2401.PubMedCrossRefGoogle Scholar
  4. 4.
    Rai, A. J., Gelfand, C. A., Haywood, B. C., et al. (2005) Human Proteome Organization-plasma proteome project specimen collection and handling: Towards the standardization of parameters for plasma proteome samples. Proteomics 5, 3262–3277.PubMedCrossRefGoogle Scholar
  5. 5.
    White, N. C., Chan, D. W., and Zhang, Z. (2004) Bioinformatics strategies for proteomic profiling. Clin. Biochem. 37, 636–641.PubMedCrossRefGoogle Scholar
  6. 6.
    Zhang, Z., Bast, R. C., Jr., Yu, Y., et al. (2004) Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer. Cancer Res. 64, 5882–5890.PubMedCrossRefGoogle Scholar
  7. 7.
    Zhang, Z. and Chan, D. W. (2005) Cancer proteomics: in pursuit of “true” biomarker discovery. Cancer Epidemiol. Biomarker Prev. 14, 2283–2286.CrossRefGoogle Scholar

Copyright information

© Humana Press Inc 2006

Authors and Affiliations

  • Daniel W. Chan

There are no affiliations available

Personalised recommendations